Journal of Molecular Medicine

, Volume 85, Issue 3, pp 293–304

Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas


    • Institut für PathologieUniversitätsklinikum Freiburg
  • Roland Weis
    • Institut für PathologieUniversitätsklinikum Freiburg
  • Frank Makowiec
    • Abteilung Allgemein- und ViszeralchirurgieUniversitätsklinikum Freiburg
  • Jasmine Roth
    • Institut für PathologieUniversitätsklinikum Freiburg
  • Mihai Danciu
    • Institut für PathologieUniversitätsklinikum Freiburg
    • Pathology Department, Faculty of MedicineUniversity of Medicine and Pharmacy, “Gr. T. Popa”
  • Ulrich Hopt
    • Abteilung Allgemein- und ViszeralchirurgieUniversitätsklinikum Freiburg
  • Martin Werner
    • Institut für PathologieUniversitätsklinikum Freiburg
Original Article

DOI: 10.1007/s00109-006-0126-5

Cite this article as:
Lassmann, S., Weis, R., Makowiec, F. et al. J Mol Med (2007) 85: 293. doi:10.1007/s00109-006-0126-5


DNA copy number changes represent molecular fingerprints of solid tumors and are as such relevant for better understanding of tumor development and progression. In this study, we applied genome-wide array comparative genomic hybridization (aCGH) to identify gene-specific DNA copy number changes in chromosomal (CIN)- and microsatellite (MIN)-unstable sporadic colorectal cancers (sCRC). Genomic DNA was extracted from microdissected, matching normal colorectal epithelium and invasive tumor cells of formalin-fixed and paraffin-embedded tissues of 22 cases with colorectal cancer (CIN = 11, MIN = 11). DNA copy number changes were determined by aCGH for 287 target sequences in tumor cell DNAs, using pooled normal DNAs as reference. aCGH data of tumor cell DNAs was confirmed by fluorescence in situ hybridization (FISH) for three genes on serial tissues as those used for aCGH. aCGH revealed DNA copy number changes previously described by metaphase CGH (gains 7, 8q, 13q, and 20q; losses 8p, 15q, 18q, and 17p). However, chromosomal regions 20q, 13q, 7, and 17p were preferentially altered in CIN-type tumors and included DNA amplifications of eight genes on chromosome 20q (TOP1, AIB1, MYBL2, CAS, PTPN1, STK15, ZNF217, and CYP24), two genes on chromosome 13q (BRCA2 and D13S25), and three genes on chromosome 7 (IL6, CYLN2, and MET) as well as DNA deletions of two genes on chromosome 17p (HIC1 and LLGL1). Finally, additional CIN-tumor-associated DNA amplifications were identified for EXT1 (8q24.11) and MYC (8q24.12) as well as DNA deletions for MAP2K5 (15q23) and LAMA3 (18q11.2). In contrast, distinct MIN-tumor-associated DNA amplifications were detected for E2F5 (8p22–q21.3), GARP (11q13.5–q14), ATM (11q22.3), KAL (Xp22.3), and XIST (Xq13.2) as well as DNA deletions for RAF1 (3p25), DCC (18q21.3), and KEN (21q tel). aCGH revealed distinct DNA copy number changes of oncogenes and tumor suppressor genes in CIN- and MIN-type sporadic colorectal carcinomas. The identified candidate genes are likely to have distinct functional roles in the carcinogenesis and progression of CIN- and MIN-type sporadic CRCs and may be involved in the differential response of CIN- and MIN-type tumor cells to (adjuvant) therapy, such as 5-fluorouracil.


Colorectal cancerGenetic instabilityOncogenesTumor suppressor genesArray CGH

Copyright information

© Springer-Verlag 2006